SCHEMBL1009963

SCHEMBL1009963

CC(C)(C)c1ccc(Nc2ccc3c(c2)OCCO3)cc1

nearest known ligand 0.69

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 14/20 0.62
MEN1 O00255 1/20 0.56
MAPT P10636 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
MTOR P42345 1/20 0.56
RAB9A P51151 1/20 0.56
KMT2A Q03164 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24777901 0.84 ADRA2A (0.61) MEN1MAPTTSHRRAB9AKMT2A
SCHEMBL4848840 0.83 TRPV1 (0.58) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL1009710 0.83 MAPT (0.52) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL24636457 0.83 TRPV1 (0.52) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL26723449 0.81 TRPV1 (0.51) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL1007796 0.81 NPC1 (0.60) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL84835 0.80 TRPV1 (0.49) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL5174946 0.79 RAB9A (0.75) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL4002053 0.79 TRPV1 (0.70) TRPV1MEN1MAPTTSHRMAPK1
SCHEMBL657416 0.79 KDM1A (0.62) MEN1MAPTTSHRMAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022191560-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2022-09-15 WO disclosed
EP-1801189-B1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE CO (US) 2012-11-07 EP disclosed
EP-1801189-B1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE CO (US) 2012-11-07 EP disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
US-8003583-B2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC (US) 2011-08-23 US disclosed
EP-1801104-B1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE CO (US) 2011-01-05 EP disclosed
US-7501386-B2 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine CHEVRON ORONITE COMPANY, LLC (US) 2009-03-10 US disclosed
US-7501386-B2 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine CHEVRON ORONITE COMPANY, LLC (US) 2009-03-10 US disclosed
US-7501386-B2 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine CHEVRON ORONITE COMPANY, LLC (US) 2009-03-10 US disclosed
EP-1801104-A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
EP-1801104-A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
EP-1801189-A2 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
EP-1801189-A2 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine Chevron Oronite Company LLC (US) 2007-06-27 EP disclosed
US-20070142243-A1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142243-A1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142243-A1 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions CHEVRON ORONITE COMPANY LLC 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142246-A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions AHR, ARNT, HRH2 TRPV1 874/4885MEN1 4728/4885MAPT 2668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.